Rein Therapeutics, Inc. · NASDAQ:RNTX
Voss Capital, LP reported a 17.00% stake in Rein Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Voss Capital, LP reported a 17.00% stake in Rein Therapeutics, Inc., 4,468,969 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 17.00%
- Shares
- 4,468,969
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Voss Value Master Fund, LP | 3.50% | 926,441 |
| Voss Value-Oriented Special Situations Fund, LP | 1.90% | 500,000 |
| Voss Advisors GP, LLC | 5.40% | 1,426,441 |
| Voss Capital, LP | 17.00% | 4,468,969 |
| Cocke Travis W. | 17.00% | 4,468,969 |
Source
Related
- Rein Therapeutics, Inc.
- Voss Capital, LP
- Rein Therapeutics, Inc. shareholders
- Schedule 13G/A · Voss Capital, LP · Jul 14, 2026
- Schedule 13G/A · Voss Capital, LP · Sep 26, 2025
- Schedule 13G · Voss Capital, LP · May 14, 2025
- Schedule 13G/A · Lynwood Capital Management Inc. · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Form 4 · Von Rickenbach Josef H · May 28, 2026
- Form 4 · Windsor James Brian · May 13, 2026